Latest Headlines

  1. Techcyte Awarded Patent, Strengthening Its AI Training Framework And Accelerating Development Of Digital Diagnostics 12/17/2025

    Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced the issuance of a new patent covering a novel approach to training medical imaging algorithms using explicit labeling.

  2. Singlera Genomics Announces Research Collaboration With The University Of Pittsburgh To Advance Pancreatic Cancer Early Detection 12/17/2025

    Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with their partner Breakthrough Genomics, a leader in the clinical analysis of genomic data and early cancer diagnostics, today announced a research collaboration with the University of Pittsburgh (Pitt) to advance the preclinical evaluation of Singlera and Breakthrough’s BT-Reveal™ Early Pancreatic Cancer Test.

  3. KPM Analytics Unveils The SmartChem® 800 Series, A Next-Generation Platform For High-Throughput Wet Chemistry 12/16/2025

    Commercial laboratories face mounting pressure to process more samples with fewer staff while maintaining fast turnaround times.

  4. Researchers Develop Groundbreaking Blood Test For Lung Cancer 12/16/2025

    A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored.

  5. Roche Announces U.S. Launch Of Next-Generation Cobas 6800/8800 Systems And Software, Enhancing Laboratory Efficiency And Testing Capabilities 12/16/2025

    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the new cobas® 6800/8800 systems version 2.0 and software version 2.0.1, following U.S. Food and Drug Administration (FDA) 510(k) clearance earlier this year.

  6. Cofactor Genomics Announces Strategic Investment By Labcorp And Ascension Ventures To Fuel Expansion Of Its OncoPrism Immunotherapy Diagnostic Across U.S. Cancer Care Networks 12/15/2025

    Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.

  7. Overture Life And CEGYR Establish First Automated Embryology Center Of Excellence To Set Global Benchmark For Reproducible IVF Outcomes Across High-Volume Fertility Networks 12/15/2025

    Overture Life, the global leader in automated IVF and the first company to achieve live births from both robotic fertilization and robotic egg freezing, today announced the establishment of its first Center of Excellence for Automated Embryology in partnership with CEGYR, a flagship fertility program within the Eugin Group.

  8. Trinity Biotech Expands Global Rollout Of High-Capacity Column System For FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances 12/15/2025

    Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has secured regulatory clearances in multiple countries, enabling the expanded rollout of its next-generation high-capacity HbA1c column system for the Premier Hb9210 analyzer which is now available in more than 10 countries, including the United States.

  9. BD Expands BD MAX™ System Menu With New IVDR-Certified VIASURE Assays In Partnership With Certest Biotec 12/15/2025

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics offerings in Europe following In Vitro Diagnostic Medical Device Regulation (IVDR) certification of two VIASURE assays developed by Certest Biotec for use on the BD MAX™ System.

  10. UM Health-Sparrow Installs First-Of-Its-Kind Lab Automation 12/12/2025

    University of Michigan Health-Sparrow activated a new, laboratory automation system that boasts drastically shorter turnaround times for lab tests. The system is among the first of its kind in the nation.